Needham analyst David Saxon reiterated a Buy rating on CryoPort today and set a price target of $12.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
David Saxon has given his Buy rating due to a combination of factors including CryoPort’s impressive third-quarter revenue performance, which surpassed market expectations. The company’s success was largely driven by its Life Sciences Services segment, and management has subsequently increased its revenue guidance for 2025.
Additionally, there is potential for further revenue growth in 2026, as suggested by management’s commentary. CryoPort is also making strides towards achieving adjusted EBITDA profitability, with the possibility of reaching this milestone by the fourth quarter of 2025. These positive developments have led to an increased price target of $12, reinforcing the Buy rating.